[MDGL] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
31-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- 61.57%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -83,948 -32,811 -31,154 -26,388 -68,671 -86,161 -90,192 -1.18%
Tax -11,136 7,871 -635 -0 0 0 0 -
NP -72,812 -32,811 -31,154 -26,388 -68,671 -86,161 -90,192 -3.50%
Tax Rate - - - - - - - -
Total Cost 72,812 32,811 31,154 26,388 68,671 86,161 90,192 -3.50%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -31.15%
EPS Diluted -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -31.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.